Financial News
Allogene Therapeutics, Inc. - Common Stock (NQ: ALLO )
2.040
+0.630
(+44.68%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 14, 2025
Add to My Watchlist
All News about Allogene Therapeutics, Inc. - Common Stock
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_303.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/87e8712c-0741-409f-9942-c91b31e7c5e1/small/allogene-png.png)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_4071.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_330.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
January 05, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/87e8712c-0741-409f-9942-c91b31e7c5e1/small/allogene-png.png)
![](https://www.investors.com/wp-content/uploads/2021/06/Stock-crispr-01-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/12/17/short_squeeze_shutter.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_24058.jpeg?width=1200&height=800&fit=crop)
Stocks That Hit 52-Week Lows On Friday
December 23, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/12/12/image45.jpg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022
December 12, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/12/08/screenshot_2022-12-08_at_7.01.58_pm.png?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/87e8712c-0741-409f-9942-c91b31e7c5e1/small/allogene-png.png)
![](https://ml.globenewswire.com/media/87e8712c-0741-409f-9942-c91b31e7c5e1/small/allogene-png.png)
![](https://ml.globenewswire.com/media/87e8712c-0741-409f-9942-c91b31e7c5e1/small/allogene-png.png)
![](https://ml.globenewswire.com/media/87e8712c-0741-409f-9942-c91b31e7c5e1/small/allogene-png.png)
![](https://ml.globenewswire.com/media/87e8712c-0741-409f-9942-c91b31e7c5e1/small/allogene-png.png)
![](https://ml.globenewswire.com/media/87e8712c-0741-409f-9942-c91b31e7c5e1/small/allogene-png.png)
![](https://ml.globenewswire.com/media/87e8712c-0741-409f-9942-c91b31e7c5e1/small/allogene-png.png)
![](https://ml.globenewswire.com/media/87e8712c-0741-409f-9942-c91b31e7c5e1/small/allogene-png.png)
Via GlobeNewswire
![](https://ml.globenewswire.com/media/87e8712c-0741-409f-9942-c91b31e7c5e1/small/allogene-png.png)
![](https://cdn.benzinga.com/files/images/story/2022/09/22/image_2.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/29/image-apple.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/29/image_3.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_24802.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_24706.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_8261.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/87e8712c-0741-409f-9942-c91b31e7c5e1/small/allogene-png.png)
![](https://cdn.benzinga.com/files/images/story/2022/07/20/42c653e5-73c4-4bc5-a724-89e510dc932f.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_20570.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_12623.jpeg?width=1200&height=800&fit=crop)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.